Clinical Trial

Adjuvant Treatment in Extensive Unilateral Retinoblastoma Primary Enucleated (RB SFCE 2009)

Study acronym: RB SFCE 09
Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
Postoperative Treatment of Unilateral Retinoblastoma After Primary Enucleation according to histopathological risk factors of the International Retinoblastoma Staging Working Group.
Protocol Amendment History 12 amendments
This ClinicalTrials.gov record has been amended 12 times since 2016-08-12; most recent amendment 2026-01-05.
Status change: Recruiting → Active, Not Recruiting 2026-01-05
Trial Details
NCT Number NCT02870907
Lead Sponsor Institut Curie
Conditions Retinoblastoma
Enrollment 195 participants
Start Date 2010-03-18
Primary Completion 2031-03-01 (estimated)
Study Completion 2031-03-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-07